In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Targacept spins-off of R.J. Reynolds; raises $30.4mm

Executive Summary

RJ Reynolds spin-off Targacept raised $30.4mm in a private placement. EuclidSR Partners led the round, and Burrill & Co., Advent Venture Partners, Auriga Ventures, CDCInnovation, Genavent, and Societe Generale Asset Management Finance, and Longleaf Venture Fund also participated. RJR still holds a minority stake in the company.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies